Research

A comparison of Māori and non-Māori patient visits to doctors: The National Primary Medical Care Survey: 2001/02: Report 6:

Crengle, S., Lay-Yee, R., Davis, P., & Pearson, J.

10 October, 2005

This report presents findings describing the experiences of Māori patients during their visits to doctors.

Pacific patterns in primary health care: A comparison of Pacific and all patient visits to doctors: The National Primary Medical Care Survey 2001/02: Report 7:

Davis, P., Suaalii-Sauni, T., Lay-Yee, R., & Pearson, J.

2 October, 2005

This study compares the experience of Pacific patients with that of the total population (including Pacific). The data was contributed by community general practices and A&M clinics.

Varying evolution of the New Zealand lung cancer epidemic by ethnicity and socioeconomic position (1981−1999):

​ Shaw, C., Blakely, T., Sarfati, D., Fawcett, J., & Hill, S.

15 April, 2005

Tobacco use and resultant health effects have been described as an epidemic that progresses through the population. This paper aimed to describe and explain trends in lung cancer mortality by ethnicity and socioeconomic position in New Zealand between 1981–1999. The authors concluded that there are significant and growing ethnic and socioeconomic inequalities in lung cancer mortality in New Zealand. In the current absence of concerted public health action these inequalities will probably widen in future decades.

The need to redefine non-cystic fibrosis bronchiectasis in childhood:

​ Eastham, K., Fall, A., Mitchell, L., & Spencer, D.

26 November, 2003

This study undertook a clinical and radiological review of 93 children with non-CF bronchiectasis. The authors concluded that while bronchiectasis is currently defined as a condition which is both permanent and progressive, this term is not necessarily appropriate for all paediatric patients.

The burden of COPD in New Zealand:

Town, I., Taylor, R., Garrett, J., & Patterson, J.

31 October, 2003

COPD is a serious condition and has a major impact on the health of people in this country. It contributes substantially to the enormous cost of tobacco smoking. The figures quoted in this report are of great concern.

Reversible bronchial dilatation in children: Comparison of serial high-resolution computer tomography scans of the lungs:

Gaillard, E., Carty, H., & Smyth, R.

9 September, 2003

Bronchiectasis is generally considered irreversible in the adult population, largely based on studies employing bronchography in cases with a significant clinical history. It is assumed that the same is true for children. The objective of this study was to evaluate changes in appearance of bronchial dilatation, unrelated to cystic fibrosis in children, as assessed by sequential high-resolution computer tomography (HRCT) of the lungs. The authors concluded that a radiological diagnosis of bronchiectasis should be considered with caution in children as diagnostic criteria derived from studies in adults have not been validated in children and the condition is generally considered irreversible.

A framework for purchasing traditional healing services: a report for the Ministry of Health:

Durie, M. H.

6 June, 1996

​This report has been prepared for the Ministry of Health to assist in the development of policies relating to the purchase and provision of traditional services.

Research Review - Managing chronic obstructive pulmonary disease (COPD) in general practice:

9 November, 2016

This publication discusses the diagnosis and management of chronic obstructive pulmonary disease (COPD) and presents the full range of treatments available for this condition in New Zealand.

Research Review Educational Series - Idiopathic Pulmonary Fibrosis:

Professor Lutz Beckert

9 January, 2017

Detailed insight into disease-background and disease-management issues.

Management of chronic obstructive pulmonary disease (COPD) - with a focus on the 2017 GOLD Strategy update:

Associate Professor Robert Young

12 July, 2017

This publication is intended as an educational resource for primary healthcare professionals managing patients with chronic obstructive pulmonary disease (COPD).